Pasar al contenido principal

DESARROLLO DE NANOSISTEMAS MULTIFUNCIONALES BASADOS EN METALO-PROFARMACOS COMBINADOS CON NANOPARTICULAS MAGNETICAS PARA APLICACIONES TERANOSTICAS.

PID2020-118448RB-C22

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Optimization of iron oxide nanoparticles for MRI-guided magnetic hyperthermia tumor therapy: reassessing the role of shape in their magnetocaloric effect

  • Páez-Muñoz, Jose María
  • Gámez, Francisco
  • Fernández-Afonso, Yilian
  • Gallardo, Roberto
  • Pernía Leal, Manuel
  • Gutiérrez, Lucía
  • Fuente, Jesús M. de la
  • Caro, Carlos
  • García-Martín, María L.
Superparamagnetic iron oxide nanoparticles have hogged the limelight in different fields of nanotechnology. Surprisingly, notwithstanding the prominent role played as agents in magnetic hyperthermia treatments, the effects of nanoparticle size and shape on the magnetic hyperthermia performance have not been entirely elucidated yet. Here, spherical or cubical magnetic nanoparticles synthesized by a thermal decomposition method with the same magnetic and hyperthermia properties are evaluated. Interestingly, spherical nanoparticles displayed significantly higher magnetic relaxivity than cubic nanoparticles; however, comparable differences were not observed in specific absorption rate (SAR), pointing out the need for additional research to better understand the connection between these two parameters. Additionally, the as-synthetized spherical nanoparticles showed negligible cytotoxicity and, therefore, were tested in vivo in tumor-bearing mice. Following intratumoral administration of these spherical nanoparticles and a single exposure to alternating magnetic fields (AMF) closely mimicking clinical conditions, a significant delay in tumor growth was observed. Although further in vivo experiments are warranted to optimize the magnetic hyperthermia conditions, our findings support the great potential of these nanoparticles as magnetic hyperthermia mediators for tumor therapy., C. Caro thanks the Regional Ministry of Health and Families for his senior postdoctoral grant (RH-0040-2021). Financial support was provided by the Spanish Ministry of Economy, Industry and Competitiveness (CTQ2017-86655-R), the Spanish Ministry of Science and Innovation (PID2020-118448RB-C21, PID2020-118448RB-C22 and PID2022-136919NA-C33) (funded by MCIN/AEI/10.13039/50110001103), the Regional Ministry of Health of Andalusia (OH-0026-2018), the Regional Ministry of Economic Transformation, Industry, Knowledge and Universities of Andalusia (PAIDI 2020. P20_00727) and European FEDER funds and the Junta de Andalucía (P18-RT-1663)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Protein corona as the key factor governing the in vivo fate of magnetic nanoparticles

  • Avasthi, Ashish
  • Fernández-Afonso, Yilian
  • Gutiérrez, Lucía
  • Fuente, Jesús M. de la
  • Pernía Leal, Manuel
  • Caro, Carlos
  • García-Martín, María L.
The data that support the findings of this study are available from the corresponding authors upon reasonable request., Advancements in the field of nanotechnology have opened a myriad of avenues for diverse applications. One such avenue is the role of nanoparticles (NPs) in the healthcare sector, whether it is drug targeting, drug delivery, or imaging, offering unprecedented prospects for improving targeted interventions along with minimal toxicity. Meanwhile, the intricate interplay between the characteristics of NPs and the ensuing biological cross-talk has engendered profound interest among scientists. Amidst the determinants shaping the behavior of NPs within the biological milieu, the biodistribution and pharmacokinetics of the NPs stand as pivotal factors intricately intertwined with their core size, hydrodynamic diameter (HD), coating ligands, as well as the proteins they interact with, forming the protein corona. This article compiles and analyzes the data to decipher the factors determining the fate of NPs in vivo. For this purpose, two IONPs with differing core sizes (≈4 nm and ≈8 nm) but coated with the same gallol-PEG ligand (GA-PEG3000-OH) and possessing very similar HDs (≈35 nm) as well as relaxivity (≈100 mM−1 s−1) were selected. Following physicochemical characterization, both protein coronas were thoroughly analyzed, revealing differences in both the composition and the relative abundance. Later, after determining the negligible cytotoxicity of both NPs, they were intravenously injected into Balb/c mice to evaluate their in vivo biodistribution and pharmacokinetics using MRI. Additionally, biodistribution was further investigated ex vivo by quantitative magnetic analysis of blood and tissues, alongside histological evaluation. Our results evidenced that the protein corona, rather than core size or hydrodynamic diameter, is the determining factor governing the in vivo fate of magnetic NPs., Financial support was provided by grant P20_00727/PAIDI2020 (to M. L. G. M.), funded by the Consejería de Transformación Económica, Industria, Conocimiento y Universidades, Junta de Andalucía, Spain; grants PID2020-118448RBC21 (to M. L. G. M.) and PID2020-118448RBC22 (to M. P. L.), funded by MCIN/AEI/10.13039/501100011033; grant CNS2023-144321 (to L. G.) funded by MICIU/AEI/10.13039/501100011033 and NextGenerationEU/PRTR. C. Caro acknowledges the support of his senior postdoctoral grant RH-0040-2021, funded by the Consejería de Salud y Familias, Junta de Andalucía. This work has also been supported by CIBER-Consorcio Centro de Investigación Biomédica en Red-(CB16/01/00263 to J. M. F.). J. M. F also acknowledges support from Gobierno de Aragón for funding the Bionanosurf (E15_20R) research group., Peer reviewed